| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
| mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.008 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
| mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
| mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |